To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene PRKCATABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
292 supporting clones for gene PRKCA back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_002737.2   .a 1 to 8770 1 to 8770 V582I RefSeq, AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 8770/8770
(100 %)
2 diff
(100.0 %id)
BC109273 PCR rescued clones .a 19 to 3022 1 to 3005   tiling clone,   3005/3005
(100 %)
3 diff
(100.0 %id)
BC109274 PCR rescued clones .a 19 to 3022 1 to 3004   tiling clone,   3004/3004
(100 %)
3 diff
(100.0 %id)
X52479 blood .a 19 to 2264 1 to 2245       2245/2245
(100 %)
6 diff
(99.8 %id)
AY633609   .a 40 to 2094 1 to 2055   tiling clone,   2055/2055
(100 %)
4 diff
(99.9 %id)
AB451258   .a 45 to 2061 1 to 2017       2017/2019
(99 %)
2 diff
(100.0 %id)
AB451383   .a 45 to 2060 1 to 2016       2016/2016
(100 %)
1 diff
(100.0 %id)
AA029890 uterus .a 60 to 502 1 to 446     Submitted on the opposite strand 446/446
(100 %)
5 diff
(98.9 %id)
DA558939   .a 75 to 633 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
M22199   .a 248 to 1379 163 to 1294       1132/1294
(87 %)
6 diff
(99.6 %id)
AA236170 germinal center B cell .a 251 to 657 406 to 1     Submitted on the opposite strand 406/471
(86 %)
2 diff
(99.6 %id)
AA030029 uterus .a 333 to 657 326 to 1     Submitted on the opposite strand 326/409
(79 %)
1 diff
(99.8 %id)
BQ367869 placenta_normal .a 427 to 682 1 to 252       252/252
(100 %)
17 diff
(93.3 %id)
AW951174   .a 435 to 937 1 to 505       505/595
(84 %)
9 diff
(98.5 %id)
AA362811 ovary .a 445 to 709 20 to 289       270/296
(91 %)
15 diff
(95.0 %id)
BF911461 uterus_tumor .a 463 to 861 399 to 2     Submitted on the opposite strand 398/406
(98 %)
2 diff
(99.6 %id)
BI060514 uterus_tumor .a 463 to 871 437 to 25       417/444
(93 %)
14 diff
(96.9 %id)
BI059577 uterus_tumor .a 466 to 618 11 to 167       157/170
(92 %)
13 diff
(92.4 %id)
DA477705   .a 466 to 1033 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
BE166138 head_neck .a 512 to 641 17 to 146       130/146
(89 %)
7 diff
(95.3 %id)
BP202229 amygdala .a 573 to 1155 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
CA454931   .a 650 to 1533 1 to 892       892/893
(99 %)
10 diff
(98.9 %id)
BF799118 colon_ins .a 679 to 1093 426 to 13     Submitted on the opposite strand 414/426
(97 %)
0 diff
(100 %id)
R16311 whole brain .a 1208 to 1558 1 to 361       361/408
(88 %)
14 diff
(96.6 %id)
BF037323 adenocarcinoma, ovary .a 1277 to 1943 1 to 662       662/662
(100 %)
7 diff
(99.0 %id)
BI856394 breast, mammary adenocarcinoma, cell line .a 1380 to 2083 1 to 704       704/711
(99 %)
4 diff
(99.5 %id)
TI_57190360   .a 1380 to 2083 48 to 751       704/711
(99 %)
4 diff
(99.5 %id)
ES310069 scalp interfollicular dermis, skin .a 1521 to 2020 1 to 498       498/507
(98 %)
10 diff
(98.1 %id)
AL596674 human spinal cord .a 1592 to 2305 1 to 715       715/715
(100 %)
2 diff
(99.8 %id)
BP325414 Pancreas .a 1986 to 2532 1 to 548       548/551
(99 %)
2 diff
(99.7 %id)
R84737 eye, retina .a 2054 to 2603 557 to 2     Submitted on the opposite strand 556/557
(99 %)
0 diff
(100 %id)
BQ018414 lung, Metastatic Chondrosarcoma .a 2127 to 2694 586 to 18       569/594
(95 %)
0 diff
(100 %id)
AF035594   .a 2210 to 3342 1 to 1158   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 1158/1158
(100 %)
8 diff
(99.4 %id)
CA420866 Bone, Enchondroma cell line .a 2236 to 2798 580 to 19   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 562/562
(100 %)
3 diff
(99.5 %id)
BF960905 nervous_normal .a 2242 to 2393 1 to 152       152/152
(100 %)
2 diff
(98.7 %id)
TI_154003793   .a 2278 to 2798 624 to 104   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 521/522
(99 %)
3 diff
(99.5 %id)
TI_154123165   .a 2309 to 2949 690 to 52       639/1079
(59 %)
0 diff
(100 %id)
AA017296 eye, retina .a 2427 to 2603 177 to 1     Submitted on the opposite strand 177/181
(97 %)
2 diff
(98.9 %id)
TI_59393726   .a 2488 to 3208 100 to 813       714/715
(99 %)
15 diff
(98.0 %id)
BM015483 breast, mammary adenocarcinoma, cell line .a 2489 to 3208 1 to 713       713/714
(99 %)
14 diff
(98.1 %id)
BF932780 nervous_tumor .a 2508 to 2698 1 to 191       191/191
(100 %)
0 diff
(100 %id)
BX106540 liver and spleen .a 2536 to 3227 1 to 693       693/693
(100 %)
2 diff
(99.8 %id)
BF950003 nervous_normal .a 2556 to 2916 370 to 15       356/399
(89 %)
0 diff
(100 %id)
TI_154128222   .a 2566 to 3342 857 to 83   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 775/960
(80 %)
12 diff
(98.8 %id)
BQ774691 Bone, Human Chondrosarcoma Cell Line .a 2692 to 3347 673 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 655/655
(100 %)
2 diff
(99.7 %id)
CB162060 Liver .a 2704 to 3248 1 to 545       545/545
(100 %)
1 diff
(99.9 %id)
CA417442 Chondrosarcoma Cell line .a 2783 to 3342 582 to 19   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 564/564
(100 %)
4 diff
(99.3 %id)
AI826635 normal prostate, Prostate .a 2888 to 3337 450 to 1       450/450
(100 %)
2 diff
(99.6 %id)
AA594863 normal prostate, Prostate .a 2892 to 3337 448 to 1       448/448
(100 %)
3 diff
(99.4 %id)
EC457945 Prostate .a 2915 to 3015 15 to 117       103/117
(88 %)
6 diff
(94.9 %id)
N70440 liver and spleen .a 2947 to 3342 400 to 1       400/464
(86 %)
12 diff
(97.5 %id)
BE464203 Kidney .a 3002 to 3344 346 to 4       343/346
(99 %)
0 diff
(100 %id)
BX648954 human amygdala .a 3032 to 8769 1 to 5736   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 5736/5736
(100 %)
4 diff
(100.0 %id)
AL707564 human skeletal muscle .a 3032 to 3703 1 to 672       672/672
(100 %)
2 diff
(99.8 %id)
AA836404 germinal center B cell .a 3149 to 3337 203 to 15   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 189/189
(100 %)
6 diff
(96.9 %id)
AV724884 hypothalamus .a 3203 to 3542 1 to 340   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 340/340
(100 %)
0 diff
(100 %id)
AF035595   .a 3263 to 3938 1 to 677       677/678
(99 %)
4 diff
(99.5 %id)
DA217325 brain .a 3279 to 3817 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA319271 hippocampus .a 3411 to 3983 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
DA340497 hippocampus .a 3448 to 4029 2 to 584   capped   583/583
(100 %)
2 diff
(99.7 %id)
DA325236 hippocampus .a 3552 to 4055 2 to 505   capped   504/504
(100 %)
3 diff
(99.5 %id)
DA314104 hippocampus .a 3578 to 4137 2 to 561   capped   560/560
(100 %)
3 diff
(99.5 %id)
DR003633 hippocampus .a 3636 to 4249 9 to 622       614/622
(98 %)
2 diff
(99.7 %id)
DA312235 hippocampus .a 3643 to 4211 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
BC107592 PCR rescued clones .a 3700 to 6157 1 to 2458       2458/2458
(100 %)
3 diff
(99.9 %id)
BC103691 PCR rescued clones .a 3700 to 6157 1 to 2458   tiling clone,   2458/2458
(100 %)
0 diff
(100 %id)
BC122530 PCR rescued clones .a 3700 to 6157 1 to 2458       2458/2458
(100 %)
0 diff
(100 %id)
DA013506 adrenal gland .a 3773 to 4308 2 to 537   capped   536/536
(100 %)
0 diff
(100 %id)
BX485042.
matches multiple genes
  .a 3887 to 4366 34 to 513     Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base), also hits gene chasweebu 480/515
(93 %)
3 diff
(99.5 %id)
DA199569 brain .a 4126 to 4711 2 to 587   capped   586/586
(100 %)
0 diff
(100 %id)
DA211527 brain .a 4264 to 4779 2 to 517   capped   516/516
(100 %)
0 diff
(100 %id)
AF086287   .a 4294 to 4809 11 to 526   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 516/516
(100 %)
0 diff
(100 %id)
W69836 heart .a 4294 to 4544 11 to 261       251/383
(65 %)
1 diff
(99.8 %id)
W69657 heart .a 4368 to 4810 446 to 1       446/446
(100 %)
6 diff
(98.7 %id)
DA220647 brain .a 4496 to 4908 2 to 414   capped   413/413
(100 %)
0 diff
(100 %id)
BI011153 lung_normal .a 4645 to 5169 525 to 1       525/525
(100 %)
8 diff
(98.5 %id)
DA336201 hippocampus .a 4757 to 5352 2 to 597   capped   596/596
(100 %)
1 diff
(99.9 %id)
DA095034 cerebellum .a 4799 to 5343 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA651871   .a 4820 to 5392 2 to 574   capped   573/574
(99 %)
3 diff
(99.5 %id)
AL119889 amygdala .a 4921 to 5233 1 to 313       313/313
(100 %)
0 diff
(100 %id)
DA196556 amygdala .a 4932 to 5494 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA220313 brain .a 4950 to 5510 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA102838 cerebellum .a 5015 to 5553 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA406426 thalamus .a 5184 to 5746 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
AW843946 colon_normal .a 5270 to 5513 7 to 249       243/249
(97 %)
6 diff
(97.6 %id)
DA406818 thalamus .a 5510 to 6069 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
AK125425 brain .a 5662 to 8768 1 to 3111   tiling clone, available from FLJ,   3111/3111
(100 %)
3 diff
(100.0 %id)
DA790313 brain .a 5663 to 6167 2 to 506   capped   505/505
(100 %)
0 diff
(100 %id)
AA376771 small intestine .a 5676 to 5927 1 to 252       252/252
(100 %)
3 diff
(98.9 %id)
BX463395 adult brain, brain .a 5752 to 6746 1 to 993       993/993
(100 %)
57 diff
(94.3 %id)
BU150006 dorsal root ganglia .a 5883 to 6648 1 to 777       777/883
(87 %)
9 diff
(99.0 %id)
DA355216 subthalamic nucleus .a 6039 to 6434 2 to 407   capped   406/406
(100 %)
7 diff
(98.3 %id)
DA525097 brain .a 6154 to 6687 2 to 536   capped   535/535
(100 %)
1 diff
(99.9 %id)
BX473074   .a 6211 to 6778 1 to 567     Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 567/567
(100 %)
1 diff
(99.9 %id)
DA293847 hippocampus .a 6256 to 6780 2 to 526   capped   525/525
(100 %)
0 diff
(100 %id)
DA294412 hippocampus .a 6256 to 6807 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA388176 thalamus .a 6303 to 6826 2 to 528   capped   527/527
(100 %)
1 diff
(99.9 %id)
DA542864   .a 6342 to 6909 2 to 569   capped   568/568
(100 %)
3 diff
(99.5 %id)
AK055431 brain .a 6348 to 8769 1 to 2423   tiling clone, available from FLJ,   2423/2423
(100 %)
3 diff
(99.9 %id)
DA515967 brain .a 6349 to 6899 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DA558938   .a 6354 to 6908 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA018149 adrenal gland .a 6409 to 6969 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BC015855 Prostate, adenocarcinoma. .a 6410 to 8768 1 to 2359   available from MGC, AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 2359/2361
(99 %)
3 diff
(99.9 %id)
BG500086 adenocarcinoma, Prostate .a 6413 to 7051 1 to 637   available from MGC,   637/637
(100 %)
2 diff
(99.7 %id)
DA913892   .a 6414 to 6970 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
H83648 eye, retina .a 6420 to 6800 8 to 388       381/388
(98 %)
24 diff
(93.9 %id)
BX090601 eye, retina .a 6427 to 7124 1 to 700       700/700
(100 %)
3 diff
(99.6 %id)
AA059269 eye, retina .a 6427 to 6791 15 to 377       363/377
(96 %)
6 diff
(98.5 %id)
AA059253 eye, retina .a 6427 to 6783 15 to 372       358/372
(96 %)
16 diff
(95.7 %id)
DA024087   .a 6456 to 7016 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA353008 substantia nigra .a 6486 to 7073 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA353275 substantia nigra .a 6486 to 7042 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA987257 synovial membrane tissue from rheumatioidarthritis .a 6599 to 7170 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
AI124798 brain, pooled frontal lobe .a 6607 to 7030 1 to 424     Submitted on the opposite strand 424/424
(100 %)
3 diff
(99.3 %id)
BQ639130 eye, retina .a 6629 to 7255 1 to 627       627/627
(100 %)
0 diff
(100 %id)
BX645282   .a 6658 to 7230 1 to 573       573/573
(100 %)
0 diff
(100 %id)
DA306317 hippocampus .a 6675 to 7236 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DA602010   .a 6742 to 7319 2 to 580   capped   579/581
(99 %)
2 diff
(99.7 %id)
DA427270 colon .a 6745 to 7230 2 to 489   capped   488/488
(100 %)
2 diff
(99.6 %id)
BQ647634 hepatocellular carcinoma, cell line, Liver .a 6821 to 7730 18 to 929       912/930
(98 %)
11 diff
(98.9 %id)
DA143543 alzheimer cortex .a 6917 to 7466 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
AA310978   .a 6950 to 7540 1 to 592       592/592
(100 %)
2 diff
(99.7 %id)
DA910120   .a 6955 to 7324 190 to 559   capped   370/558
(66 %)
6 diff
(99.0 %id)
BF215415 brain, glioblastoma .a 7000 to 7654 1 to 648   available from MGC,   648/704
(92 %)
23 diff
(96.8 %id)
BC071767 Brain, glioblastoma .a 7001 to 8766 1 to 1766   available from MGC, AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 1766/1768
(99 %)
1 diff
(100.0 %id)
DN993793 brain, whole brain .a 7014 to 7588 1 to 575       575/575
(100 %)
0 diff
(100 %id)
BM463848 leiomyosarcoma, uterus .a 7034 to 7969 1 to 954       954/1056
(90 %)
35 diff
(96.7 %id)
DA664309   .a 7053 to 7899 2 to 849   capped   848/848
(100 %)
4 diff
(99.6 %id)
BQ424758 leiomyosarcoma, uterus .a 7110 to 7994 30 to 918       889/918
(96 %)
6 diff
(99.4 %id)
BM685785 eye, Retina Foveal and Macular .a 7118 to 7736 9 to 626     Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 618/626
(98 %)
1 diff
(99.9 %id)
BX473075   .a 8175 to 8769 643 to 49   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 595/595
(100 %)
2 diff
(99.7 %id)
DB326559 brain .a 8220 to 8768 549 to 1       549/549
(100 %)
0 diff
(100 %id)
BU726162 eye, Retina Foveal and Macular .a 8320 to 8769 467 to 18   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 450/450
(100 %)
0 diff
(100 %id)
AA059225 eye, retina .a 8384 to 8768 395 to 1       395/400
(98 %)
9 diff
(97.8 %id)
H83649 eye, retina .a 8497 to 8748 252 to 1       252/252
(100 %)
0 diff
(100 %id)
AA059219 eye, retina .a 8541 to 8768 228 to 1       228/228
(100 %)
0 diff
(100 %id)
DB316828 brain .a 8571 to 8769 200 to 1       200/200
(100 %)
1 diff
(99.5 %id)
AB209475 brain .b 1 to 6007 1 to 6007 A315V tiling clone,   6007/6007
(100 %)
22 diff
(99.7 %id)
BG744141 blood, natural killer cells, cell line .c 1 to 794 1 to 794   tiling clone,   794/928
(85 %)
18 diff
(98.1 %id)
BG744804 blood, natural killer cells, cell line .c 1075 to 1805 735 to 1   tiling clone,   735/736
(99 %)
12 diff
(98.4 %id)
BQ706322 Spleen .d 1 to 628 15 to 645   tiling clone,   631/931
(67 %)
13 diff
(98.7 %id)
BC053321 Lung, epidermoid carcinoma .d 229 to 1956 1 to 1730 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/17 A in genome downstream of last aligned base) 1730/1730
(100 %)
10 diff
(99.5 %id)
BU528370 epidermoid carcinoma, cell line, lung .d 230 to 649 1 to 420   available from MGC,   420/928
(45 %)
1 diff
(99.9 %id)
AW168082 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 398 to 1053 1 to 656     Submitted on the opposite strand 656/656
(100 %)
1 diff
(99.9 %id)
TI_157596610   .d 399 to 1107 41 to 747     Submitted on the opposite strand 707/968
(73 %)
14 diff
(98.6 %id)
AW138441   .d 400 to 732 1 to 333     Submitted on the opposite strand 333/427
(77 %)
2 diff
(99.6 %id)
BX090063 uterus .d 401 to 1094 694 to 1     Submitted on the opposite strand 694/694
(100 %)
0 diff
(100 %id)
AW003761 Kidney .d 421 to 1057 1 to 637     Submitted on the opposite strand 637/637
(100 %)
8 diff
(98.8 %id)
AA236171 germinal center B cell .d 460 to 733 1 to 277     Submitted on the opposite strand 277/316
(87 %)
8 diff
(97.5 %id)
AI033775 parathyroid gland, parathyroid tumor .d 460 to 649 1 to 190     Submitted on the opposite strand 190/536
(35 %)
1 diff
(99.9 %id)
AI885267 anaplastic oligodendroglioma, brain .d 460 to 1073 1 to 614     Submitted on the opposite strand 614/614
(100 %)
4 diff
(99.4 %id)
BM020079 astrocytoma grade IV, cell line, brain .d 777 to 1542 1 to 778       778/778
(100 %)
22 diff
(97.2 %id)
TI_59390859   .d 778 to 1428 101 to 755       655/777
(84 %)
10 diff
(98.8 %id)
BG109474 Bone, osteosarcoma, cell line .d 1675 to 2264 1 to 599   tiling clone,   599/605
(99 %)
30 diff
(95.1 %id)
AA598416 lung, lung carcinoma .d 2056 to 2256 201 to 1   tiling clone,   201/201
(100 %)
2 diff
(99.1 %id)
CR987715 T-Lymphocytes .e 1 to 855 1 to 855 exact tiling clone,   855/855
(100 %)
6 diff
(99.3 %id)
DA517005 brain .e 348 to 886 2 to 540   capped   539/539
(100 %)
2 diff
(99.7 %id)
BQ638926 eye, retina .e 625 to 1256 1 to 632   tiling clone,   632/632
(100 %)
1 diff
(99.9 %id)
BX493378   .e 766 to 1303 1 to 538   tiling clone,   538/538
(100 %)
2 diff
(99.7 %id)
DA355815 subthalamic nucleus .f-u 1 to 546 2 to 547   tiling clone, capped   546/546
(100 %)
0 diff
(100 %id)
BC062759 Brain, glioblastoma .f-u 78 to 1620 4 to 1546 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 1543/1543
(100 %)
1 diff
(100.0 %id)
BF215725 brain, glioblastoma .f-u 78 to 758 1 to 684   available from MGC,   684/868
(78 %)
11 diff
(98.8 %id)
BM746433 stomach .f-u 80 to 646 1 to 566       566/566
(100 %)
2 diff
(99.7 %id)
BF340066 brain, glioblastoma with EGFR amplification .f-u 93 to 893 1 to 800       800/879
(91 %)
21 diff
(97.7 %id)
H14878 whole brain .f-u 96 to 508 1 to 424       424/424
(100 %)
15 diff
(96.5 %id)
H10801 whole brain .f-u 134 to 668 1 to 536     Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 536/579
(92 %)
24 diff
(95.9 %id)
CA405605 adipose .f-u 135 to 779 1 to 644       644/644
(100 %)
1 diff
(99.9 %id)
AL702506 human skeletal muscle .f-u 147 to 577 1 to 431       431/431
(100 %)
0 diff
(100 %id)
BE311471 Kidney, renal cell adenocarcinoma .f-u 166 to 848 1 to 678       678/712
(95 %)
14 diff
(98.1 %id)
CF597281 ovary .f-u 208 to 953 1 to 747 R89K     747/747
(100 %)
3 diff
(99.6 %id)
CD252231 White Matter .f-u 259 to 937 20 to 701 V88G I90N D104N R106K G107R ...     682/886
(76 %)
20 diff
(97.8 %id)
W92662 liver and spleen .f-u 353 to 749 1 to 402       402/404
(99 %)
10 diff
(97.6 %id)
CF456736 peripheral nervous system .f-u 362 to 1166 31 to 828 L58W A59Q G60E G61E G62D ...     798/933
(85 %)
12 diff
(98.8 %id)
BF218925 brain, glioblastoma .f-u 456 to 1155 1 to 692 D45T P48L C49A S50P V51*     692/883
(78 %)
36 diff
(96.0 %id)
R85041 brain .f-u 471 to 870 1 to 412       412/484
(85 %)
19 diff
(96.1 %id)
W22645 eye, retina .f-u 518 to 1207 699 to 11 L2P C3S L6*     689/700
(98 %)
0 diff
(100 %id)
BE737614 brain, glioblastoma .f-u 540 to 1195 1 to 645 L58W A59Q G60E G61E G62D ...     645/847
(76 %)
21 diff
(97.6 %id)
BI000497 head_normal .f-u 552 to 786 257 to 18       240/269
(89 %)
0 diff
(100 %id)
AA424937 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 580 to 1031 1 to 449       449/449
(100 %)
7 diff
(98.5 %id)
BQ650650 hepatocellular carcinoma, cell line, Liver .f-u 641 to 1449 1 to 824       824/979
(84 %)
16 diff
(98.4 %id)
BQ647186 hepatocellular carcinoma, cell line, Liver .f-u 641 to 1153 1 to 517       517/1251
(41 %)
45 diff
(96.5 %id)
BQ651141 hepatocellular carcinoma, cell line, Liver .f-u 641 to 1541 1 to 914       914/916
(99 %)
29 diff
(96.9 %id)
BE087536 breast .f-u 660 to 1209 15 to 564       550/564
(97 %)
6 diff
(99.0 %id)
W22971 eye, retina .f-u 670 to 1189 563 to 38       526/565
(93 %)
0 diff
(100 %id)
BE738596 brain, glioblastoma .f-u 704 to 1548 879 to 38       842/979
(86 %)
0 diff
(100 %id)
BF745221 breast .f-u 734 to 1128 10 to 404       395/404
(97 %)
6 diff
(98.6 %id)
BQ649553 hepatocellular carcinoma, cell line, Liver .f-u 756 to 1247 115 to 606       492/1005
(48 %)
25 diff
(97.6 %id)
BU540088 mixed (pool of 40 RNAs) .f-u 827 to 1621 1 to 795       795/795
(100 %)
3 diff
(99.7 %id)
BU625592 cell lines, Enchondroma .f-u 858 to 1621 782 to 19   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 764/764
(100 %)
5 diff
(99.4 %id)
CA432244 cell lines, Enchondroma .f-u 877 to 1621 763 to 19   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 745/745
(100 %)
0 diff
(100 %id)
BQ010062 Chondrosarcoma, Left Pubic Bone .f-u 880 to 1621 756 to 19   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 738/738
(100 %)
6 diff
(99.2 %id)
TI_154127370   .f-u 881 to 1623 823 to 88   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 736/929
(79 %)
8 diff
(99.2 %id)
CA417000 Chondrosarcoma Cell line .f-u 881 to 1623 754 to 19   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 736/737
(99 %)
8 diff
(99.0 %id)
CB047129 2 pooled tumors (clear cell type), Kidney .f-u 882 to 1438 1 to 557       557/557
(100 %)
5 diff
(99.2 %id)
CA424521 cell lines, Chondrosarcoma .f-u 889 to 1623 753 to 19   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 735/735
(100 %)
2 diff
(99.8 %id)
H41204 brain .f-u 891 to 1291 1 to 402   fully sequenced,   402/402
(100 %)
1 diff
(99.8 %id)
H46341 brain .f-u 891 to 1333 1 to 452   fully sequenced,   452/452
(100 %)
16 diff
(96.5 %id)
BQ447368 Knee, Osteoarthritic Cartilage .f-u 892 to 1621 748 to 19   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 730/730
(100 %)
1 diff
(99.9 %id)
BM692975 eye, Retina Foveal and Macular .f-u 897 to 1350 1 to 454   fully sequenced, Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 454/454
(100 %)
2 diff
(99.6 %id)
AA100008   .f-u 907 to 1268 1 to 364   fully sequenced,   364/364
(100 %)
2 diff
(99.5 %id)
BQ005840 Chondrosarcoma, Left Pubic Bone .f-u 921 to 1589 706 to 37   AAA   670/690
(97 %)
0 diff
(100 %id)
TI_149291978   .f-u 935 to 1621 761 to 76   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 686/821
(83 %)
6 diff
(99.3 %id)
BM719764 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f-u 950 to 1550 1 to 600       600/600
(100 %)
1 diff
(99.9 %id)
BM746897 Ascites, stomach .f-u 983 to 1496 1 to 515       515/515
(100 %)
6 diff
(98.9 %id)
FN138172 breast carcinoma .f-u 993 to 1110 1 to 118       118/120
(98 %)
1 diff
(99.2 %id)
BQ719583 sympathetic trunk .f-u 999 to 1621 1 to 623       623/632
(98 %)
1 diff
(99.9 %id)
BU682345 lung .f-u 1008 to 1621 633 to 19   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 615/615
(100 %)
2 diff
(99.7 %id)
AI928468 Kidney .f-u 1010 to 1621 634 to 23   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 612/617
(99 %)
1 diff
(99.9 %id)
BM472989 duodenal adenocarcinoma, cell line, small intestine .f-u 1018 to 1621 1 to 604       604/1065
(56 %)
21 diff
(98.1 %id)
AI471375 colon, moderately-differentiated adenocarcinoma .f-u 1022 to 1625 605 to 1       605/605
(100 %)
21 diff
(96.6 %id)
BF223020 pooled germ cell tumors .f-u 1031 to 1622 592 to 1       592/592
(100 %)
1 diff
(99.9 %id)
AW969261   .f-u 1039 to 1620 582 to 1     Submitted on the opposite strand 582/583
(99 %)
3 diff
(99.5 %id)
BM995258 Chondrosarcoma, Left Pubic Bone .f-u 1040 to 1621 600 to 19   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 582/582
(100 %)
1 diff
(99.9 %id)
DB467204 hippocampus .f-u 1041 to 1495 1 to 452       452/452
(100 %)
3 diff
(99.4 %id)
AI744505 pooled .f-u 1047 to 1622 582 to 7       576/582
(98 %)
0 diff
(100 %id)
AI972672 Prostate .f-u 1047 to 1621 575 to 1       575/575
(100 %)
1 diff
(99.9 %id)
BF055332 pooled .f-u 1056 to 1622 575 to 9       567/575
(98 %)
0 diff
(100 %id)
AW467141 2 pooled tumors (clear cell type), Kidney .f-u 1074 to 1621 549 to 3       547/549
(99 %)
0 diff
(100 %id)
BU618330 Cell Line, Chondrosarcoma .f-u 1074 to 1622 567 to 19   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 549/549
(100 %)
1 diff
(99.9 %id)
AW966568   .f-u 1085 to 1621 595 to 60   AAA Submitted on the opposite strand 536/538
(99 %)
8 diff
(98.6 %id)
BG026392 Bone, osteosarcoma, cell line .f-u 1087 to 1621 1 to 530   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 530/530
(100 %)
11 diff
(98.0 %id)
AI567496 anaplastic oligodendroglioma, brain .f-u 1111 to 1622 512 to 1   tiling clone,   512/512
(100 %)
0 diff
(100 %id)
AA029096 uterus .f-u 1124 to 1416 1 to 295   fully sequenced,   295/295
(100 %)
2 diff
(99.4 %id)
AW131619 brain, medulloblastoma .f-u 1126 to 1621 499 to 4       496/499
(99 %)
0 diff
(100 %id)
AA865606 2 pooled tumors (clear cell type), Kidney .f-u 1128 to 1622 499 to 5       495/499
(99 %)
0 diff
(100 %id)
AI417072 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1128 to 1621 502 to 9       494/502
(98 %)
0 diff
(100 %id)
AI435797 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1129 to 1622 494 to 1       494/494
(100 %)
0 diff
(100 %id)
AW005039 anaplastic oligodendroglioma, brain .f-u 1129 to 1622 494 to 1       494/494
(100 %)
1 diff
(99.8 %id)
AI590097 anaplastic oligodendroglioma, brain .f-u 1143 to 1622 480 to 1       480/480
(100 %)
1 diff
(99.8 %id)
AI524340 Prostate .f-u 1144 to 1621 479 to 2       478/479
(99 %)
0 diff
(100 %id)
AI378901 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1145 to 1622 478 to 1       478/478
(100 %)
0 diff
(100 %id)
AI763379 colon, colon tumor, RER+ .f-u 1145 to 1621 481 to 5       477/481
(99 %)
0 diff
(100 %id)
AI862568 2 pooled tumors (clear cell type), Kidney .f-u 1145 to 1621 480 to 4       477/480
(99 %)
0 diff
(100 %id)
AW771547 Kidney .f-u 1146 to 1621 476 to 1       476/476
(100 %)
0 diff
(100 %id)
AW272479 pooled .f-u 1155 to 1622 472 to 5       468/472
(99 %)
0 diff
(100 %id)
AI371754 pooled germ cell tumors .f-u 1156 to 1622 467 to 1       467/467
(100 %)
0 diff
(100 %id)
AA633573   .f-u 1157 to 1621 466 to 2       465/466
(99 %)
0 diff
(100 %id)
BQ017371 lung, Metastatic Chondrosarcoma .f-u 1158 to 1627 488 to 19   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 470/470
(100 %)
2 diff
(99.6 %id)
AW270723 brain, three pooled meningiomas .f-u 1161 to 1621 461 to 1       461/461
(100 %)
0 diff
(100 %id)
AW273108 colon, moderately-differentiated adenocarcinoma .f-u 1162 to 1622 461 to 2       460/461
(99 %)
0 diff
(100 %id)
AI393766 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1163 to 1622 460 to 1       460/460
(100 %)
0 diff
(100 %id)
AW014963   .f-u 1165 to 1621 474 to 18   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 457/457
(100 %)
0 diff
(100 %id)
AI333003 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1168 to 1622 455 to 1       455/455
(100 %)
0 diff
(100 %id)
AI378421 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1168 to 1621 464 to 11   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 454/454
(100 %)
0 diff
(100 %id)
AW966572   .f-u 1169 to 1621 512 to 60   AAA Submitted on the opposite strand 453/453
(100 %)
6 diff
(98.7 %id)
H10780 whole brain .f-u 1172 to 1621 466 to 13   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 454/454
(100 %)
6 diff
(98.7 %id)
AW888701 nervous_tumor .f-u 1176 to 1472 1 to 296       296/296
(100 %)
7 diff
(97.7 %id)
AI912819 Kidney .f-u 1176 to 1621 446 to 1       446/446
(100 %)
0 diff
(100 %id)
AW337262 adenocarcinoma, Pancreas .f-u 1176 to 1622 473 to 27   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 447/447
(100 %)
0 diff
(100 %id)
AI922052 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .f-u 1181 to 1627 459 to 13   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 447/447
(100 %)
0 diff
(100 %id)
AW051382 pooled .f-u 1181 to 1622 447 to 6       442/447
(98 %)
0 diff
(100 %id)
AI167582 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1188 to 1622 435 to 1       435/435
(100 %)
0 diff
(100 %id)
AI823944 2 pooled tumors (clear cell type), Kidney .f-u 1190 to 1621 448 to 16   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 433/433
(100 %)
1 diff
(99.8 %id)
CB046956 2 pooled tumors (clear cell type), Kidney .f-u 1191 to 1621 21 to 451       431/451
(95 %)
6 diff
(98.7 %id)
AI367159 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1196 to 1621 431 to 6       426/431
(98 %)
0 diff
(100 %id)
AI283255 adenocarcinoma, colon .f-u 1198 to 1622 425 to 1       425/425
(100 %)
1 diff
(99.8 %id)
DB534189 hippocampus .f-u 1205 to 1620 1 to 416     Submitted on the opposite strand 416/418
(99 %)
1 diff
(99.8 %id)
W93283 liver and spleen .f-u 1220 to 1622 408 to 3       406/409
(99 %)
0 diff
(100 %id)
AI452891 pooled .f-u 1223 to 1621 399 to 1       399/399
(100 %)
0 diff
(100 %id)
AA424938 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1227 to 1622 396 to 1       396/396
(100 %)
1 diff
(99.8 %id)
AA113025   .f-u 1238 to 1625 392 to 1   fully sequenced,   392/392
(100 %)
5 diff
(98.8 %id)
BF115173 Kidney .f-u 1238 to 1623 386 to 1       386/386
(100 %)
0 diff
(100 %id)
AI220170 pooled .f-u 1251 to 1621 372 to 2       371/372
(99 %)
0 diff
(100 %id)
AA921731 adenocarcinoma, colon .f-u 1252 to 1622 371 to 1       371/371
(100 %)
0 diff
(100 %id)
H41205 brain .f-u 1261 to 1566 307 to 1   fully sequenced,   307/307
(100 %)
2 diff
(99.4 %id)
BQ003239 Chondrosarcoma, Left Pelvis .f-u 1263 to 1621 377 to 19   AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 359/359
(100 %)
5 diff
(98.7 %id)
AA468715 colon .f-u 1277 to 1621 348 to 4       345/348
(99 %)
0 diff
(100 %id)
AW194640 Kidney .f-u 1287 to 1621 338 to 3       336/338
(99 %)
0 diff
(100 %id)
AI471163 brain, glioblastoma (pooled) .f-u 1297 to 1621 324 to 1       324/324
(100 %)
6 diff
(98.2 %id)
AA693859 liver and spleen .f-u 1301 to 1621 321 to 1       321/321
(100 %)
0 diff
(100 %id)
H46270 brain .f-u 1303 to 1614 323 to 9   fully sequenced,   315/323
(97 %)
4 diff
(98.8 %id)
BM668313 eye, Retina Foveal and Macular .f-u 1320 to 1621 320 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (22/25 A in genome downstream of last aligned base) 302/302
(100 %)
2 diff
(99.4 %id)
AA889368 pooled .f-u 1324 to 1621 299 to 2       298/299
(99 %)
0 diff
(100 %id)
AW590192 pooled germ cell tumors .f-u 1332 to 1620 294 to 6       289/294
(98 %)
0 diff
(100 %id)
AI784476 anaplastic oligodendroglioma, brain .f-u 1333 to 1622 288 to 1       288/288
(100 %)
3 diff
(99.0 %id)
BF446973 Prostate .f-u 1356 to 1621 266 to 1       266/266
(100 %)
4 diff
(98.5 %id)
AI470844 Kidney .f-u 1382 to 1621 247 to 7       241/247
(97 %)
0 diff
(100 %id)
AA029097 uterus .f-u 1386 to 1616 235 to 1   fully sequenced,   235/235
(100 %)
2 diff
(99.2 %id)
AA836679 brain, substantia nigra .f-u 1401 to 1622 224 to 3       222/224
(99 %)
0 diff
(100 %id)
AA235234 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .f-u 1432 to 1616 1 to 185       185/185
(100 %)
0 diff
(100 %id)
AI424711 brain, glioblastoma (pooled) .f-u 1436 to 1621 186 to 1       186/186
(100 %)
0 diff
(100 %id)
AI040599 liver and spleen .f-u 1443 to 1621 180 to 1       180/180
(100 %)
1 diff
(99.5 %id)
R93247 liver and spleen .f-u 1512 to 1599 88 to 1       88/88
(100 %)
0 diff
(100 %id)
EC519882 Prostate .f-u 1514 to 1621 1 to 107       107/109
(98 %)
6 diff
(94.5 %id)
AI913205 adenocarcinoma, Pancreas .f-u 1554 to 1622 76 to 8       69/84
(82 %)
0 diff
(100 %id)
AA627718 colon, colon tumor RER+ .g 1 to 519 1 to 516 Q2R L3S G5A G6V G7E ... tiling clone, Submitted on the opposite strand 516/516
(100 %)
10 diff
(98.1 %id)
AA491850 Liver .h 1 to 316 321 to 5 exact tiling clone,   317/321
(98 %)
0 diff
(100 %id)
AK130736 synovial membrane (knee) .i-u 1 to 2508 1 to 2506 K48T H49S P50T Q51N I52K ... tiling clone, available from FLJ,   2506/2506
(100 %)
2 diff
(100.0 %id)
BF927764 nervous_tumor .i-u 1128 to 1415 288 to 1     Submitted on the opposite strand 288/288
(100 %)
1 diff
(99.7 %id)
AW850250 colon .i-u 1271 to 1916 646 to 1       646/646
(100 %)
3 diff
(99.6 %id)
AW841312 colon_normal .i-u 1293 to 1520 1 to 226       226/227
(99 %)
3 diff
(98.7 %id)
AW841364 colon_normal .i-u 1293 to 1520 1 to 226       226/227
(99 %)
3 diff
(98.7 %id)
AW841418 colon_normal .i-u 1295 to 1520 227 to 2       226/228
(99 %)
0 diff
(100 %id)
AW850253 colon .i-u 1393 to 1936 544 to 1       544/544
(100 %)
16 diff
(97.1 %id)
AW850255 colon .i-u 1416 to 1885 471 to 1       471/472
(99 %)
8 diff
(98.4 %id)
AW856010 colon .i-u 1565 to 1789 310 to 85       226/310
(72 %)
0 diff
(100 %id)
BE146507 head_neck .i-u 1565 to 2018 460 to 8     Submitted on the opposite strand 453/460
(98 %)
0 diff
(100 %id)
AW473148 serous papillary carcinoma, high grade, 2pooled tumors, uterus .i-u 2151 to 2509 359 to 1       359/359
(100 %)
1 diff
(99.8 %id)
AW472785 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .i-u 2172 to 2510 339 to 1   tiling clone,   339/339
(100 %)
0 diff
(100 %id)
BI493687 cochlea, ear .i-u 2207 to 2500 8 to 301   fully sequenced, AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 294/301
(97 %)
6 diff
(98.1 %id)
BI493686 cochlea, ear .i-u 2321 to 2489 169 to 1   fully sequenced, Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 169/169
(100 %)
2 diff
(98.9 %id)
AK098118 trachea .j-u 1 to 2030 2 to 2031 P60S tiling clone, available from FLJ,   2087/2662
(78 %)
14 diff
(99.5 %id)
DB199430 trachea .j-u 1 to 566 2 to 568 P60S capped   567/567
(100 %)
3 diff
(99.5 %id)
AA346795 heart .j-u 99 to 335 1 to 237   tiling clone,   237/237
(100 %)
0 diff
(100 %id)
BG401705 Kidney .k-u 1 to 725 1 to 714 R56G G57A C58V tiling clone,   714/872
(81 %)
23 diff
(97.4 %id)
DB311893 thalamus Gene PRKCA, variant not shown         This clone was ignored    
DA394356 thalamus Gene PRKCA, variant not shown       capped This clone was ignored    
AW005527 anaplastic oligodendroglioma, brain Gene PRKCA, variant not shown         This clone was ignored    
BF541197 hypernephroma, Kidney Gene PRKCA, variant not shown              
BC101403 PCR rescued clones Gene PRKCA, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g, .h, .i-u, .j-u, .k-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI